![Virtual Booth](https://www.pharmacompass.com/image/vb/vb-orange-btn.png)
![Minakem Generic APIs](https://www.pharmacompass.com/image/flap/minakem-header-desktop-w27gif-57924.gif)
![Minakem Generic APIs](https://www.pharmacompass.com/image/flap/minakem-header-mobile-w27gif-62411.gif)
01 Dr. Reddy's Laboratories (3)
02 Egis Pharmaceuticals PLC (3)
03 Alembic Pharmaceuticals Limited (3)
04 CRYSTAL (3)
05 Farmaprojects S.A.U (3)
06 Laurus Labs (3)
07 Novartis Pharmaceuticals Corporation (5)
08 Novartis South Africa (Pty) Ltd (3)
09 Tecnimede (3)
10 Torrent Pharmaceuticals Limited (3)
11 Blank (6)
01 CAPSULE, PELLETS;ORAL (2)
02 Coated Tablet (3)
03 Film Coated Tablet (10)
04 Film Coated Tablet; Film Coated Tablet (2)
05 Oral Solid Dosage Form (3)
06 TAB (3)
07 TABLET;ORAL (12)
08 Tablet (3)
01 Generic (3)
02 Lead Market Dossiers- Filed (3)
03 RX (14)
04 Blank (18)
01 28 Entresto 24/26Mg Film-Coated Tablets (1)
02 28 Neparvis 24/26Mg Film-Coated Tablets (1)
03 56 Entresto 49/51Mg Film-Coated Tablets (1)
04 56 Entresto 97/103Mg Film-Coated Tablets (1)
05 56 Neparvis 49/51Mg Film-Coated Tablets (1)
06 56 Neparvis 97/103Mg Film-Coated Tablets (1)
07 ENTRESTO (3)
08 ENTRESTO SPRINKLE (2)
09 SACUBITRIL AND VALSARTAN (9)
10 Vymada 100 mg (1)
11 Vymada 200 mg (1)
12 Vymada 50 mg (1)
13 Blank (15)
01 Hungary (3)
02 India (6)
03 Portugal (3)
04 South Africa (3)
05 Spain (9)
06 USA (14)